MarketCapTrends
VRDN
Viridian Therapeutics Inc. (VRDN)
NASDAQ · Healthcare

Viridian Therapeutics Inc. Cash on Hand 2013–2025

Viridian Therapeutics Inc. annual/quarterly cash on hand history from 2013 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Viridian Therapeutics Inc. cash on hand for the quarter ending December 31, 2025 were 874.7M, a 21.89% increase year-over-year.
  • Viridian Therapeutics Inc. cash on hand for 2025 were 874.7M, a 21.89% increase from 2024.
  • Viridian Therapeutics Inc. cash on hand for 2024 were 717.6M, a 50.31% increase from 2023.
  • Viridian Therapeutics Inc. cash on hand for 2023 were 477.4M, a 12.44% increase from 2022.
  • Viridian Therapeutics Inc. cash on hand for 2022 were 424.6M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Viridian Therapeutics Inc. Annual Cash on Hand (Millions of US $)
2025$875
2024$718
2023$477
2022$425
2021$197
2020$128
2019$27
2018$33
2017$47
2016$22
2015$21
2014$5
2013$0
Viridian Therapeutics Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$875
2024-12-31$718
2023-12-31$477
2022-12-31$425
2021-12-31$197
2020-12-31$128
2019-12-31$27
2018-12-31$33
2017-12-31$47
2016-12-31$22
2015-12-31$21
2014-12-31$5
2013-12-31$0

Viridian Therapeutics Inc. Cash on Hand — FAQ

Viridian Therapeutics Inc. (VRDN) cash on hand over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VRDN's cash on hand history?

The chart and table above show Viridian Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.